NSAIDs
In the treatment of osteoarthritis, rofecoxib has been shown to be as effective       as traditional NSAIDs and may cause fewer endoscopically documented ulcers, but       its complete adverse-effect profile is not known.
In the  @PREDICAT$  of  @OBJECT$ , rofecoxib has been shown to be as effective       as traditional  @SUBJECT$  and may cause fewer endoscopically documented ulcers, but       its complete adverse-effect profile is not known.